Artiva Biotherapeutics, Inc. - 8-K Filing
Artiva Biotherapeutics stockholders approved a $5,097,095 share increase to its 2024 Equity Incentive Plan at the September 8 annual meeting. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits (d) Exhibits ExhibitNumber Description 10)
Tickers: $ARTV